Skip to main content
. 2023 Apr 27;14:1145441. doi: 10.3389/fimmu.2023.1145441

Figure 2.

Figure 2

Effects of Dec and Aza on the exhaustion and phenotypic differentiation of CD44v6 CAR-T. (A, B) TIM3, LAG3 and PD-1 expression levels of non-transduced T (NT) and CD44v6 CAR-T cells treated with Dec (0.05, 0.1 μM) (A) and Aza (0.5, 1 μM) (B) for 6 days (n=4). (C) CD69 expression level of NT and CD44v6 CAR-T cells treated with Dec (0.05, 0.1 μM) (left) and Aza (0.5, 1 μM) (right) for 6 days (n=4) (D, E) CCR7 and CD45RA surface staining was performed on NT and CD44v6 CAR-T cells (n=5) treated with Dec (0.05, 0.1 μM) and Aza (0.5, 1 μM) for 6 days, representative flow cytometry is shown in D, the changes of phenotype of CD44v6 CAR-T cells are indicated in (E) MFI, mean fluorescence intensity; Teff, effector T cells; Tcm, central memory T cells; Tem, effector memory T cells. Data are depicted as the mean ± SD. *p<.05; **p<.01; ***p<.001; ****p<.0001; ns, not significant.